Bharat Biotech said another interim analysis and a final one is expected in the weeks ahead, which will give a more robust picture of Covaxin's efficacy.

Tune in to this podcast for all the latest news on the COVID-19 pandemic.

The Moderna vaccine turned eligible for COVAX supplies after the World Health Organisation (WHO) issued an emergency use listing on April 30.

Delhi hospital first issues then withdraws a notice asking nurses to refrain from speaking in languages other than English or Hindi, or risk serious action against them.

WHO said fake COVID-19 vaccines should be identified and weeded out as they pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems.

India’s high levels of air pollution have expanded geographically over time. Compared to a couple decades ago, particulate pollution is no longer a feature of the Indo-Gangetic plains alone. The recent data from AQLI the underscores the health threat of a…

Inclusion of indigenously developed Covaxin in the WHO list will boost global acceptance of the Covid-19 vaccine.

Persons with non-severe COVID-19 who are nonetheless at high risk of hospitalisation can take the antibody combo, as should critically ill patients unable to mount an adequate immune response, according to a WHO finding published in BMJ.

Hyderabad-based Bharat Biotech had submitted clinical trial data on Covaxin to the WHO in July in its application for EUA.

Plus, Indonesia opens with 5-day mandatory quarantine; Abu Dhabi resumes tourist visa submissions.

With the EUL status accorded by the WHO, more countries are expected to add Covaxin to the list of recognised vaccines. But until then, many Indians with overseas travel plans are left in the lurch.

The official has said since Covaxin is a virion-inactivated vaccine. 'it covers the entire virus and can work against this highly mutated new variant'. Covaxin maker Bharat Biotech has not said anything about the jab's efficacy against the new strain

"This is yet another milestone in our fight against COVID-19, Covovax is now W.H.O. approved for emergency use, showing excellent safety and efficacy," SII chief executive officer Adar Poonawalla tweeted.

Boosters may not be the answer but masks and social-distancing may be, plus a continent prepares to live with the virus and India gets a warning from Red Cross

Covid news highlights: China's COVID-19 data is not giving an accurate picture of the situation there and underrepresents the number of hospitalisations and deaths from the disease, a senior official at the World Health Organization said.